AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
66 hedge funds and large institutions have $17.2M invested in Accelerate Diagnostics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
72% less call options, than puts
Call options by funds: $8K | Put options by funds: $29K
Holders
66
Holding in Top 10
–
Calls
$8K
Puts
$29K
Top Buyers
| 1 | +$1.18M | |
| 2 | +$108K | |
| 3 | +$70K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$40.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$35K |
Top Sellers
| 1 | -$437K | |
| 2 | -$173K | |
| 3 | -$112K | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$82.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72.1K |